Finance

Roสปyxatlar
Nega BMRN tushdi 2,29%?
Batafsil oสปrganish
BMRN:NASDAQ
Biomarin Pharmaceutical Inc
56,22ย US$
-2,29%
(-1,32) 1K
56,25ย US$
+0,05% (+0,030)
Birjadan oldin
Savdolar yopilgan: 6-okt, 16:00:01 (GMT-4)  ·   USD
Barcha belgilar
BelgiNarxiOสปzgartirishlarDinamika (%)
BMRN tikeri uchun statistika yaratilmoqda...
Ochish
57,54ย US$
Yuqori
57,88ย US$
Past
55,76ย US$
Bozor kapitali
10,81ย mlrd
Oสปrtacha hajm
1,96ย mln
Hajmi
4,97ย ming
P/E koeffitsiyenti
151,56
52 haftalik eng yuqori
70,98ย US$
52 haftalik eng past
49,26ย US$
Aksiya boสปyicha daromad
0,37ย US$
Beta
0,22
Muomaladagi aksiyalar
193,57ย mln
Xodimlar soni
3ย ming
Ochish
57,54ย US$
Yuqori
57,88ย US$
Past
55,76ย US$
Bozor kapitali
10,81ย mlrd
Oสปrtacha hajm
1,96ย mln
Hajmi
4,97ย ming
P/E koeffitsiyenti
151,56
52 haftalik eng yuqori
70,98ย US$
52 haftalik eng past
49,26ย US$
Aksiya boสปyicha daromad
0,37ย US$
Beta
0,22
Muomaladagi aksiyalar
193,57ย mln
Xodimlar soni
3ย ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Profil
BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research are in enzyme replacement therapies. BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I, by manufacturing laronidase. BioMarin was also the first company to provide therapeutics for phenylketonuria. Over the years, BioMarin has been criticised for drug pricing and for specific instances of denying access to drugs in clinical trials. Wikipedia
Biomarin Pharmaceutical Inc haqida
CEOAlexander Hardy
Xodimlar soni3,22ย ming
Asos solinganmar 1997
Bosh ofislarSan Rafael, Kaliforniya, Amerika Qoโ€˜shma Shtatlari
Sektor-
Veb-saytbiomarin.com
Analitik reytinglar
Oxirgi 3 oyda BMRN aksiyalari boสปyicha reyting bergan 22 tahlilchi xulosasiga koสปra
Sotib olish tavsiya etiladi
Sotib olish
17
Ushlab qolish
5
Sotish
0
12 oylik prognoz
Oxirgi 3 oyda BMRN uchun 12 oylik narx maqsadlarini taklif qilgan 22 Wall Street tahlilchisi xulosasiga koสปra
Eng yuqori
Joriy 56,22ย US$
124,00ย US$ (+120,56%)
Oโ€˜rtacha
93,15ย US$ (+65,69%)
Eng past
60,00ย US$ (+6,72%)
Analitik
Tavsiya
Amal
Kutilayotgan narx
Prognoz
Sana
Jessica Fye
J.P. Morgan
Buy
Maintained
86,00ย US$
+53%
09/21/2026
Debjit Chattopadhyay
Guggenheim
Buy
Maintained
86,00ย US$
+53%
09/17/2026
Sean Laaman
Morgan Stanley
Buy
Reiterated
124,00ย US$
+120,6%
09/16/2026
David Lebowitz
BMO Capital
Buy
Reiterated
97,00ย US$
+72,5%
09/16/2026
Unknown Analyst
BMO Capital
Buy
Maintained
97,00ย US$
+72,5%
09/15/2026
Eric Joseph
Citi
Buy
Reiterated
-
-
09/14/2026
Mohit Bansal
Wells Fargo
Buy
Maintained
80,00ย US$
+42,3%
09/11/2026
Mitchell Kapoor
H.C. Wainwright
Hold
Reiterated
60,00ย US$
+6,7%
09/10/2026
Salveen Richter
Goldman Sachs
Hold
Maintained
70,00ย US$
+24,5%
08/31/2026
Olivia Brayer
Cantor Fitzgerald
Buy
Maintained
86,00ย US$
+53%
09/01/2026
Whitney Ijem
Canaccord Genuity
Buy
Maintained
114,00ย US$
+102,8%
08/31/2026
Allison Bratzel
Piper Sandler
Buy
Maintained
90,00ย US$
+60,1%
09/01/2026
Akash Tewari
Jefferies
Buy
Maintained
105,00ย US$
+86,8%
08/31/2026
Sami Corwin
William Blair
Hold
Maintained
-
-
08/31/2026
Paul Matteis
Stifel Nicolaus
Hold
Maintained
70,00ย US$
+24,5%
08/31/2026
Jason Gerberry
Bank of America Securities
Buy
Maintained
86,00ย US$
+53%
08/18/2026
Phil Nadeau
TD Cowen
Buy
Maintained
120,00ย US$
+113,4%
08/20/2026
Yun Zhong
Wedbush
Buy
Maintained
94,00ย US$
+67,2%
08/18/2026
Eliana Merle
Barclays
Buy
Maintained
111,00ย US$
+97,4%
08/17/2026
Christopher Raymond
Raymond James
Buy
Maintained
105,00ย US$
+86,8%
08/07/2026
Cory Kasimov
Evercore ISI
Buy
Maintained
120,00ย US$
+113,4%
08/07/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
97,00ย US$
+72,5%
08/07/2026
Luca Issi
RBC Capital
Hold
Maintained
62,00ย US$
+10,3%
08/07/2026
Jason Zemansky
Bank of America Securities
Buy
Reiterated
86,00ย US$
+53%
08/06/2026
Unknown Analyst
Guggenheim
Buy
Maintained
86,00ย US$
+53%
06/03/2026
Unknown Analyst
J.P. Morgan
Buy
Maintained
80,00ย US$
+42,3%
05/20/2026
Unknown Analyst
Citi
Buy
Initiated
-
-
05/19/2026
Joseph Schwartz
Leerink Partners
Hold
Reiterated
62,00ย US$
+10,3%
05/18/2026
William Pickering
Bernstein
Buy
Reiterated
82,00ย US$
+45,9%
05/05/2026
Joon Lee
Truist Financial
Buy
Maintained
-
-
03/03/2026
Oxirgi hisobot
6-avg, 2026
Moliya davri
Ch.2 2026
Aksiya boสปyicha taxminiy daromad (USD)
1,20ย US$ / 0,95ย US$
+25,75%musbat
Taxminiy daromad (USD)
989,71ย mln / 932,04ย mln
+6,19%musbat
Q2 2026 uchun tushumlar hisoboti
Tushumlar hisoboti kutilmoqda
Qisqacha
Oxirgi yangiliklar va hisobotlar sarhisobi
Avvalgi hisobotlarBarcha qiymatlar โ€“ USD
Loading Previous Earnings...
Daromad
Sof foyda
Barcha qiymatlar โ€“ USD
sen, 2025
dek, 2025
mar, 2026
iyn, 2026
Daromad
776,13ย mln
874,56ย mln
766,21ย mln
989,71ย mln
Sotilgan mahsulotning tannarxi
549,56ย mln
348,91ย mln
373,80ย mln
398,05ย mln
Daromad narxi
549,56ย mln
348,91ย mln
373,80ย mln
398,05ย mln
Tadqiqot va ishlanmalarga xarajatlar
-
-
-
-
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar
-
-
-
-
Tijoriy, umumiy va maสผmuriy xarajatlar
268,42ย mln
324,16ย mln
249,98ย mln
308,73ย mln
Operatsion xarajatlar
273,26ย mln
329,01ย mln
254,46ย mln
382,22ย mln
Jami operatsion xarajatlar
822,82ย mln
677,92ย mln
628,26ย mln
780,27ย mln
Operatsion daromad
-46,69ย mln
196,64ย mln
137,95ย mln
209,44ย mln
Boshqa nooperatsion daromad
5,09ย mln
1,02ย mln
3,96ย mln
3,28ย mln
Soliq toสปlangunga qadar foyda, shu jumladan gสปayrioddiy moddalar
-26,32ย mln
-27,15ย mln
141,20ย mln
61,38ย mln
Soliq toสปlangunga qadar foyda, gสปayrioddiy moddalar bundan mustasno
-26,32ย mln
214,10ย mln
149,52ย mln
159,91ย mln
Daromad soligสปi boสปyicha xarajat
4,42ย mln
19,42ย mln
35,68ย mln
16,62ย mln
Amaldagi soliq stavkasi
-16,79%
-71,52%
25,27%
27,08%
Boshqa operatsion xarajatlar
-
-
-
-
Sof foyda
-30,74ย mln
-46,57ย mln
105,53ย mln
44,76ย mln
Sof foyda marjasi
-3,96%
-5,33%
13,77%
4,52%
Har bir aksiya foydasi
0,12
0,46
0,76
1,20
Foizlar va investitsiyalardan olingan daromadlar
17,85ย mln
19,21ย mln
22,56ย mln
10,48ย mln
Foizlarni toสปlash xarajatlari
-2,58ย mln
-2,78ย mln
-14,96ย mln
-63,30ย mln
Foizlarni toสปlash boสปyicha sof xarajatlar
15,28ย mln
16,43ย mln
7,60ย mln
-52,82ย mln
Amortizatsiya ajratmalari
-
-
-
-
EBITDA
-28,20ย mln
209,68ย mln
154,36ย mln
307,08ย mln
Aktivlarni sotishdan olingan foyda yoki zarar
-
-
-
-
Insayder tranzaksiyalari
Insayder tranzaksiyalari maสผlumotlari tashqi manbalardan olingan. Batafsil
Insayder
Joylashuvi
Turi
Sana
Aksiyalar
Miqdor
1-sahifa
AI kontentda xatolar boสปlishi mumkin. Batafsil
Google ilovalari